ARTICLE
|
doi:10.20944/preprints202308.0948.v1
Subject:
Medicine And Pharmacology,
Internal Medicine
Keywords:
Molnupiravir; SARS-CoV-2; COVID-19; Nirmatrelvir; oral antiviral
Online: 11 August 2023 (13:23:50 CEST)
ARTICLE
|
doi:10.20944/preprints202306.0059.v1
Subject:
Medicine And Pharmacology,
Epidemiology And Infectious Diseases
Keywords:
COVID-19; SARS-CoV-2; remdesivir; nirmatrelvir; variant; synergy; antiviral; immunosuppressed
Online: 1 June 2023 (08:00:38 CEST)
REVIEW
|
doi:10.20944/preprints202308.0055.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
COVID-19; SARS-CoV-2 Mpro; protease inhibitors; coronavirus; peptidomimetics; Paxlovid; Nirmatrelvir
Online: 2 August 2023 (05:25:21 CEST)
ARTICLE
|
doi:10.20944/preprints202206.0272.v1
Subject:
Medicine And Pharmacology,
Pulmonary And Respiratory Medicine
Keywords:
COVID-19; SARS-CoV-2; molnupiravir; nirmatrelvir; GC376; PF-07321332; variant; synergy; an-tiviral
Online: 20 June 2022 (10:57:26 CEST)
ARTICLE
|
doi:10.20944/preprints202404.1825.v1
Subject:
Biochemistry And Molecular Biology,
Biology And Life Sciences
Keywords:
main protease (Mpro); ivermectin; nirmatrelvir; SARS-CoV-2; molecular docking; molecular dynamics
Online: 28 April 2024 (07:07:33 CEST)